Back to Journals » Virus Adaptation and Treatment » Volume 2

An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies

Authors S Chinnaswamy, H Cai, C Kao

Published 22 June 2010 Volume 2010:2 Pages 73—89

DOI https://doi.org/10.2147/VAAT.S9641

Review by Single-blind

Peer reviewer comments 4

S Chinnaswamy, H Cai, C Kao

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA

Abstract: Chronic infection by the hepatitis C virus (HCV) can lead to liver cirrhosis and hepatocellular carcinoma. There is currently no prophylactic vaccine against HCV, and the treatment is currently limited to modified interferon and ribavirin. The RNA-dependent RNA polymerase (RdRp) of HCV is an attractive target for inhibitor development, and this has led to active efforts in the development of nucleoside and non-nucleoside inhibitors. The HCV polymerase is also one of the model systems for detailed analysis of how RdRp structure affects the mechanism of RNA synthesis. This review summarizes current efforts with inhibitors targeting the HCV RdRp and how the various inhibitors affect the mechanism of RNA synthesis.

Keywords: HCV infection, RdRp, nucleoside inhibitors, subgenomic replicons, ProTides, ribavirin, allosteric site

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Phosphorylation of the viral coat protein regulates RNA virus infection

Hoover HS, Kao CC

Virus Adaptation and Treatment 2016, 8:13-20

Published Date: 24 November 2016

Mapping protein–RNA interactions

Vaughan R, Running W, Qi R, Kao CC

Virus Adaptation and Treatment 2012, 4:29-41

Published Date: 2 May 2012

Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease

J Ortiz-Alcantara, K Bhardwaj, S Palaninathan, et al.

Virus Adaptation and Treatment 2010, 2:125-133

Published Date: 6 September 2010

Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase

Sreedhar Chinnaswamy, Ayaluru Murali, Hui Cai, et al

Virus Adaptation and Treatment 2010, 2:21-39

Published Date: 11 March 2010

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010